SANDESH SETH Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SANDESH SETH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SANDESH SETH. SANDESH SETH is CEO in Actinium Pharmaceuticals, Inc. ($ATNM) and Chairman & CEO in Actinium Pharmaceuticals, Inc. ($CTVN) and Chairman and CEO in Actinium Pharmaceuticals, Inc. ($CTVN) and Chief Executive Officer in Actinium Pharmaceuticals, Inc. ($ATNM) and Director in Actinium Pharmaceuticals, Inc. ($CTVN) and Executive Chairman in Actinium Pharmaceuticals, Inc. ($CTVN) and Director in RELMADA THERAPEUTICS, INC. ($RLMD).
Latest Insider Trading Transactions of SANDESH SETH
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 14 2020 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | Chief Executive Off ... | Option Exercise | A | 9.55 | 139,062 | 1,328,042 | 139,062 | |
Jul 16 2019 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | CEO | Option Exercise | A | 0.23 | 1,500,000 | 348,000 | 1,500,000 | |
Feb 21 2019 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Buy | X | 0.60 | 8,125 | 4,875 | 161,458 | 153.3 K to 161.5 K (+5.30 %) |
Feb 21 2019 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Buy | X | 0.60 | 8,125 | 4,875 | 161,458 | 153.3 K to 161.5 K (+5.30 %) |
Dec 10 2018 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Buy | P | 0.44 | 10,000 | 4,372 | 153,333 | 143.3 K to 153.3 K (+6.98 %) |
Jul 17 2018 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | CEO | Option Exercise | A | 0.78 | 1,000,000 | 782,900 | 1,000,000 | |
Jul 17 2018 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | CEO | Buy | P | 0.79 | 10,000 | 7,900 | 143,333 | 133.3 K to 143.3 K (+7.50 %) |
Apr 20 2018 | ATNM | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Buy | P | 0.38 | 5,000 | 1,900 | 133,333 | 128.3 K to 133.3 K (+3.90 %) |
Mar 08 2018 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Option Exercise | J | 0.70 | 39,375 | 27,563 | 39,375 | |
Mar 08 2018 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Option Exercise | J | 0.60 | 13,125 | 7,875 | 13,125 | |
Mar 08 2018 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Buy | J | 0.50 | 52,500 | 26,250 | 128,333 | 75.8 K to 128.3 K (+69.23 %) |
Aug 04 2017 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Buy | P | 0.75 | 33,333 | 25,000 | 75,833 | 42.5 K to 75.8 K (+78.43 %) |
Jun 15 2017 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman and CEO | Buy | P | 1.16 | 5,000 | 5,800 | 42,500 | 37.5 K to 42.5 K (+13.33 %) |
Jun 15 2017 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman and CEO | Buy | P | 1.16 | 5,000 | 5,800 | 42,500 | 37.5 K to 42.5 K (+13.33 %) |
Jun 15 2017 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman and CEO | Buy | P | 1.17 | 2,500 | 2,925 | 37,500 | 35 K to 37.5 K (+7.14 %) |
Jun 15 2017 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman and CEO | Buy | P | 1.17 | 2,500 | 2,925 | 37,500 | 35 K to 37.5 K (+7.14 %) |
Jan 03 2017 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Executive Chairman | Buy | P | 0.88 | 5,000 | 4,400 | 35,000 | 30 K to 35 K (+16.67 %) |
Dec 12 2016 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Executive Chairman | Buy | P | 0.98 | 5,000 | 4,900 | 30,000 | 25 K to 30 K (+20.00 %) |
Apr 18 2016 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Director | Option Exercise | A | 1.99 | 500,000 | 995,000 | 500,000 | |
Apr 18 2016 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Director | Buy | P | 1.99 | 1,500 | 2,985 | 25,000 | 23.5 K to 25 K (+6.38 %) |
Apr 18 2016 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Director | Buy | P | 1.98 | 5,000 | 9,900 | 23,500 | 18.5 K to 23.5 K (+27.03 %) |
Apr 18 2016 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Director | Buy | P | 2.01 | 1,500 | 3,015 | 18,500 | 17 K to 18.5 K (+8.82 %) |
Apr 18 2016 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Director | Buy | P | 2.00 | 2,000 | 4,000 | 17,000 | 15 K to 17 K (+13.33 %) |
Apr 18 2016 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Director | Buy | P | 2.00 | 5,000 | 10,000 | 15,000 | 10 K to 15 K (+50.00 %) |
Dec 17 2015 | RLMD | RELMADA THERAPEUTI ... | SETH SANDESH | Director | Buy | P | 3.50 | 2,400 | 8,400 | 123,258 | 120.9 K to 123.3 K (+1.99 %) |
Dec 17 2015 | RLMD | RELMADA THERAPEUTI ... | SETH SANDESH | Director | Buy | P | 3.43 | 100 | 343 | 120,858 | 120.8 K to 120.9 K (+0.08 %) |
Dec 17 2015 | RLMD | RELMADA THERAPEUTI ... | SETH SANDESH | Director | Buy | P | 3.30 | 2,500 | 8,250 | 120,758 | 118.3 K to 120.8 K (+2.11 %) |
Dec 17 2015 | RLMD | RELMADA THERAPEUTI ... | SETH SANDESH | Director | Buy | P | 2.91 | 2,000 | 5,820 | 118,258 | 116.3 K to 118.3 K (+1.72 %) |
Dec 17 2015 | RLMD | RELMADA THERAPEUTI ... | SETH SANDESH | Director | Buy | P | 3.00 | 2,500 | 7,500 | 116,258 | 113.8 K to 116.3 K (+2.20 %) |
Dec 16 2015 | RLMD | RELMADA THERAPEUTI ... | SETH SANDESH | Director | Buy | P | 3.00 | 1,500 | 4,500 | 113,758 | 112.3 K to 113.8 K (+1.34 %) |
Dec 16 2015 | RLMD | RELMADA THERAPEUTI ... | SETH SANDESH | Director | Buy | P | 2.99 | 5,000 | 14,950 | 112,258 | 107.3 K to 112.3 K (+4.66 %) |
Dec 16 2015 | RLMD | RELMADA THERAPEUTI ... | SETH SANDESH | Director | Buy | P | 2.97 | 1,000 | 2,970 | 107,258 | 106.3 K to 107.3 K (+0.94 %) |
Dec 16 2015 | RLMD | RELMADA THERAPEUTI ... | SETH SANDESH | Director | Buy | P | 2.90 | 500 | 1,450 | 106,258 | 105.8 K to 106.3 K (+0.47 %) |
Dec 16 2015 | RLMD | RELMADA THERAPEUTI ... | SETH SANDESH | Director | Buy | P | 2.89 | 1,560 | 4,508 | 105,758 | 104.2 K to 105.8 K (+1.50 %) |
Dec 16 2015 | RLMD | RELMADA THERAPEUTI ... | SETH SANDESH | Director | Buy | P | 2.50 | 140 | 350 | 104,198 | 104.1 K to 104.2 K (+0.13 %) |
Dec 16 2015 | RLMD | RELMADA THERAPEUTI ... | SETH SANDESH | Director | Buy | P | 2.50 | 800 | 2,000 | 104,058 | 103.3 K to 104.1 K (+0.77 %) |
Mar 16 2015 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Executive Chairman | Option Exercise | A | 3.58 | 150,000 | 537,000 | 150,000 |
Page: 1